InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,156.31
(
0.42%
)

Replies to post #303 on Revance Therapeutics Inc (RVNC)

Replies to #303 on Revance Therapeutics Inc (RVNC)

DewDiligence

06/21/18 6:37 PM

#422 RE: DewDiligence #303

RVNC doses first phase-3 cervical-dystonia patient:

#msg-141709137
#msg-141711745

DewDiligence

06/06/19 6:33 PM

#931 RE: DewDiligence #303

EOLS’ CFO (who used to be RVNC’s CFO) said something noteworthy in the breakout session after yesterday’s Jefferies webcast. She said that RVNC’s phase-2 data in CD are amazing.